デフォルト表紙
市場調査レポート
商品コード
1663311

頬骨および翼状骨インプラント:市場洞察・競合情勢・市場予測 (~2032年)

Zygomatic and Pterygoid Implant - Market Insights, Competitive Landscape, and Market Forecast - 2032


出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
頬骨および翼状骨インプラント:市場洞察・競合情勢・市場予測 (~2032年)
出版日: 2025年02月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

頬骨および翼状骨インプラントの市場規模は、予測期間中はCAGR 5.78%で成長すると予測されています。

頬骨および翼突骨インプラントの需要は、主に世界の口腔疾患や外傷の有病率の上昇によって牽引されています。歯周病、無歯顎症、顎顔面外傷などの症状は、歯の喪失や上顎骨の劣化の主な原因であり、高度なインプラントソリューションに対する大きなニーズを生み出しています。

医療上の必要性に加え、審美的な歯科治療に対する需要の高まりも市場の成長に拍車をかけています。頬骨および翼状骨インプラントは、複雑な多段階手術の必要性を排除し、治療期間を短縮することで、従来の骨移植手順に代わる費用対効果の高い選択肢を提供します。これらの要素は、患者の利便性を向上させるだけでなく、全体的な結果を向上させることから、これらのインプラントは、患者と医師の双方にとって魅力的な選択肢となっています。

市場力学:

世界保健機関 (WHO) の2023年のデータによると、世界人口の約19%にあたる10億人以上の成人が重度の歯周病に罹患しています。進行した歯周病 (歯周炎) は歯槽骨の破壊をもたらし、従来の歯科インプラントの構造的支持を著しく損ないます。特に頬骨インプラントや翼状骨インプラントは、上顎の骨が著しく失われた患者に対応します。これらのインプラントは、頬骨や翼状骨のような密度の高い骨に固定することで、骨移植の必要性をなくし、歯科補綴物の安定した土台を提供します。

歯周病に加え、外傷もこのような特殊なインプラントの需要に大きく貢献しています。PubMed Centralに掲載された2023年の研究によると、米国では年間約4,000万件の外傷による救急外来 (ED) 受診があると報告されています。自動車事故、転倒、スポーツ関連事故、暴力などによる顔面外傷は、しばしば上顎骨 (上顎骨) に大きな損傷を与え、従来のインプラントの埋入を妨げています。頬骨および翼状骨インプラントは、このような場合に特に有益であり、従来の方法では不十分な場合に、フルマウスリハビリテーションのための強固なソリューションを提供します。

もう一つの主要な促進要因は、審美的な歯科ソリューションに対する需要の増加です。口腔の審美性と顔の対称性に関する意識の高まりにより、患者は歯の機能性と見た目を同時に改善する処置に傾倒しています。大掛かりな骨移植を必要とする従来のインプラントとは異なり、頬骨インプラントと翼状骨インプラントは、長期的な安定性を備えた、より迅速で侵襲性の低いソリューションを提供します。これらのインプラントは、治療を長引かせることなく、即時の負荷プロトコルと生活の質の向上を求める患者にとって特に価値のあるものです。

当レポートでは、世界の頬骨および翼状骨インプラントの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 頬骨および翼状骨インプラント市場レポート:イントロダクション

第2章 頬骨および翼状骨インプラント市場:エグゼクティブサマリー

  • 市場概要

第3章 競合情勢

第4章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第5章 頬骨および翼状骨インプラント市場:主要要因分析

  • 市場促進要因
    • 世界での口腔疾患や外傷の罹患率の増加
    • 審美歯科ソリューションの需要の高まり
    • 骨移植と比較した費用対効果
  • 市場抑制要因と課題
    • 手術に伴う術後合併症
    • 患者の適性と代替治療オプションの有無
  • 市場機会
    • 外傷後および腫瘍学の用途における頬骨および翼状骨インプラントの使用拡大

第6章 頬骨および翼状骨インプラント市場:ポーターのファイブフォース分析

第7章 頬骨および翼状骨インプラント市場:市場の評価

  • インプラントタイプ別
    • 頬骨インプラント
    • 翼状骨インプラント
  • 用途別
    • 上顎洞
    • 重度上顎萎縮
    • その他
  • エンドユーザー別
    • 病院
    • 歯科医院
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 頬骨および翼状骨インプラント市場:企業と製品のプロファイル

  • Danaher Corporation
  • Noris Medical
  • Biotec Dental Impant
  • SIN Implant System
  • IDC Implant & Dental Company
  • BioLine Dental Implants
  • Southern Implants
  • B&B Dental Implant Company
  • BioHorizons
  • Titaniumfix
  • Implance
  • Institut Straumann AG
  • DSI Dental Solutions
  • JDentalCare
  • Adin Dental Implant Systems Ltd.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項・問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Zygomatic and Pterygoid Implant Market in Global (2022-2032)
  • Table 3: Zygomatic and Pterygoid Implant Market in Global by Implant Type (2022-2032)
  • Table 4: Zygomatic and Pterygoid Implant Market in Global by Application (2022-2032)
  • Table 5: Zygomatic and Pterygoid Implant Market in Global by End-User (2022-2032)
  • Table 6: Zygomatic and Pterygoid Implant Market in Global by Geography (2022-2032)
  • Table 7: Zygomatic and Pterygoid Implant Market in North America (2022-2032)
  • Table 8: Zygomatic and Pterygoid Implant Market in the United States (2022-2032)
  • Table 9: Zygomatic and Pterygoid Implant Market in Canada (2022-2032)
  • Table 10: Zygomatic and Pterygoid Implant Market in Mexico (2022-2032)
  • Table 11: Zygomatic and Pterygoid Implant Market in Europe (2022-2032)
  • Table 12: Zygomatic and Pterygoid Implant Market in France (2022-2032)
  • Table 13: Zygomatic and Pterygoid Implant Market in Germany (2022-2032)
  • Table 14: Zygomatic and Pterygoid Implant Market in United Kingdom (2022-2032)
  • Table 15: Zygomatic and Pterygoid Implant Market in Italy (2022-2032)
  • Table 16: Zygomatic and Pterygoid Implant Market in Spain (2022-2032)
  • Table 17: Zygomatic and Pterygoid Implant Market in the Rest of Europe (2022-2032)
  • Table 18: Zygomatic and Pterygoid Implant Market in Asia-Pacific (2022-2032)
  • Table 19: Zygomatic and Pterygoid Implant Market in China (2022-2032)
  • Table 20: Zygomatic and Pterygoid Implant Market in Japan (2022-2032)
  • Table 21: Zygomatic and Pterygoid Implant Market in India (2022-2032)
  • Table 22: Zygomatic and Pterygoid Implant Market in Australia (2022-2032)
  • Table 23: Zygomatic and Pterygoid Implant Market in South Korea (2022-2032)
  • Table 24: Zygomatic and Pterygoid Implant Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Zygomatic and Pterygoid Implant Market in the Rest of the World (2022-2032)
  • Table 26: Zygomatic and Pterygoid Implant Market in the Middle East (2022-2032)
  • Table 27: Zygomatic and Pterygoid Implant Market in Africa (2022-2032)
  • Table 28: Zygomatic and Pterygoid Implant Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Zygomatic and Pterygoid Implant Market in Global (2022-2032)
  • Figure 3: Zygomatic and Pterygoid Implant Market in Global by Implant Type (2022-2032)
  • Figure 4: Zygomatic and Pterygoid Implant Market in Global by Application (2022-2032)
  • Figure 5: Zygomatic and Pterygoid Implant Market in Global by End-User (2022-2032)
  • Figure 6: Zygomatic and Pterygoid Implant Market in Global by Geography (2022-2032)
  • Figure 7: Zygomatic and Pterygoid Implant Market in North America (2022-2032)
  • Figure 8: Zygomatic and Pterygoid Implant Market in the United States (2022-2032)
  • Figure 9: Zygomatic and Pterygoid Implant Market in Canada (2022-2032)
  • Figure 10: Zygomatic and Pterygoid Implant Market in Mexico (2022-2032)
  • Figure 11: Zygomatic and Pterygoid Implant Market in Europe (2022-2032)
  • Figure 12: Zygomatic and Pterygoid Implant Market in France (2022-2032)
  • Figure 13: Zygomatic and Pterygoid Implant Market in Germany (2022-2032)
  • Figure 14: Zygomatic and Pterygoid Implant Market in United Kingdom (2022-2032)
  • Figure 15: Zygomatic and Pterygoid Implant Market in Italy (2022-2032)
  • Figure 16: Zygomatic and Pterygoid Implant Market in Spain (2022-2032)
  • Figure 17: Zygomatic and Pterygoid Implant Market in the Rest of Europe (2022-2032)
  • Figure 18: Zygomatic and Pterygoid Implant Market in Asia-Pacific (2022-2032)
  • Figure 19: Zygomatic and Pterygoid Implant Market in China (2022-2032)
  • Figure 20: Zygomatic and Pterygoid Implant Market in Japan (2022-2032)
  • Figure 21: Zygomatic and Pterygoid Implant Market in India (2022-2032)
  • Figure 22: Zygomatic and Pterygoid Implant Market in Australia (2022-2032)
  • Figure 23: Zygomatic and Pterygoid Implant Market in South Korea (2022-2032)
  • Figure 24: Zygomatic and Pterygoid Implant Market in Rest of Asia-Pacific (2022-2032)
  • Figure 25: Zygomatic and Pterygoid Implant Market in the Rest of the World (2022-2032)
  • Figure 26: Zygomatic and Pterygoid Implant Market in the Middle East (2022-2032)
  • Figure 27: Zygomatic and Pterygoid Implant Market in Africa (2022-2032)
  • Figure 28: Zygomatic and Pterygoid Implant Market in South America (2022-2032)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0391

Zygomatic and Pterygoid Implant market by Implant Type (Zygomatic Implants and Pterygoid Implants), Application (Maxillary Sinuses, Severe Maxillary Atrophy, and Others), End-Users (Hospitals, Dental Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the increasing prevalence of oral disorders and trauma around the globe and growing demand for aesthetic dental solutions.

The Zygomatic and Pterygoid Implant market is estimated to grow at a CAGR of 5.78% during the forecast period from 2025 to 2032. The demand for zygomatic and pterygoid implants is primarily driven by the rising prevalence of oral disorders and traumatic injuries worldwide. Conditions such as periodontal disease, edentulism, and maxillofacial trauma are leading causes of tooth loss and upper jawbone deterioration, creating a significant need for advanced implant solutions.

In addition to medical necessity, the growing demand for aesthetic dental solutions is fueling market growth, as patients increasingly seek treatments that restore both functionality and appearance. Zygomatic and pterygoid implants offer a cost-effective alternative to traditional bone grafting procedures by eliminating the need for complex, multi-stage surgeries and reducing treatment timelines. These factors not only improve patient convenience but also enhance overall outcomes, making these implants an attractive option for both patients and clinicians.

As a result, the zygomatic and pterygoid implant market is expected to experience substantial growth during the forecast period of 2025 to 2032, driven by clinical benefits, increasing patient awareness, and technological advancements in implantology..

Zygomatic and Pterygoid Implant Market Dynamics:

According to the World Health Organization (WHO) 2023 data, over 1 billion adults approximately 19% of the global population are affected by severe periodontal diseases. As one of the leading causes of adult tooth loss, advanced periodontal disease (periodontitis) results in the destruction of the alveolar bone, severely compromising the structural support for traditional dental implants. This increasing prevalence is driving the demand for alternative implant solutions, particularly zygomatic and pterygoid implants, which cater to patients with significant bone loss in the upper jaw. These implants eliminate the need for bone grafting by anchoring into denser bones such as the zygomatic bone (cheekbone) or pterygoid plate, providing a stable foundation for dental prosthetics.

In addition to periodontal disease, traumatic injuries significantly contribute to the demand for these specialized implants. A 2023 study published in PubMed Central reported that approximately 40 million emergency department (ED) visits occur annually in the United States due to traumatic injuries. Facial trauma from motor vehicle accidents, falls, sports-related incidents, or violence often leads to substantial upper jawbone (maxilla) damage, hindering the placement of conventional implants. Zygomatic and pterygoid implants are particularly beneficial in such cases, offering a robust solution for full-mouth rehabilitation when traditional methods fall short.

Another key growth driver is the increasing demand for aesthetic dental solutions. Rising awareness about oral aesthetics and facial symmetry has made patients more inclined toward procedures that simultaneously improve dental functionality and appearance. Unlike traditional implants requiring extensive bone grafting, zygomatic and pterygoid implants provide a quicker, less invasive solution with long-term stability. They are especially valuable for patients seeking immediate loading protocols and improved quality of life without prolonged treatment timelines.

Given these factors, the zygomatic and pterygoid implant market is expected to witness significant growth during the forecast period of 2025 to 2032. The combination of increasing cases of severe bone loss (due to periodontal diseases and trauma), heightened patient expectations for aesthetic outcomes, and the clinical advantages of these implants over conventional solutions is driving market expansion.

However, certain challenges may temper this growth. Post-surgical complications, patient-specific anatomical limitations, and the availability of alternative treatment options such as bone grafting and sinus lift procedures pose constraints. Additionally, the high cost of advanced implant procedures and the requirement for specialized surgical expertise could limit adoption, particularly in developing regions.

Zygomatic and Pterygoid Implant Market Segment Analysis:

Zygomatic and Pterygoid Implant market by Implant Type (Zygomatic Implants and Pterygoid Implants), Application (Maxillary Sinuses, Severe Maxillary Atrophy, and Others), End-Users (Hospitals, Dental Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the zygomatic and pterygoid implant market, the zygomatic implants category is projected to secure a significant revenue share in 2024. This growth can be attributed to the distinct advantages and broad applications offered by these specialized implants.

Zygomatic implants are specifically designed for patients experiencing severe bone loss in the upper jaw (maxilla) a common limitation for the placement of traditional dental implants. These implants range from 30 mm to 52.5 mm in length, significantly longer than conventional implants, to reach and anchor into the zygomatic bone (cheekbone). By bypassing the atrophic maxillary bone, they eliminate the need for bone grafting and associated procedures like sinus lifts, making them a more efficient treatment option for patients with extensive bone resorption.

The aging global population plays a pivotal role in driving demand. Increasing cases of edentulism (complete tooth loss) and atrophic maxilla among older adults necessitate innovative solutions like zygomatic implants. For many patients, traditional implant procedures involve multiple surgeries, prolonged healing periods, and higher complication risks. In contrast, zygomatic implants can often be placed in a single surgical procedure with the possibility of immediate loading, allowing for faster restoration of dental function and aesthetics. This quick turnaround not only improves patient comfort but also reduces overall treatment time and costs.

Furthermore, growing patient awareness of dental aesthetics, combined with the rising demand for full-mouth rehabilitation solutions, positions zygomatic implants as a preferred option. Their ability to offer long-term stability and support for implant-supported prosthetics without complex pre-treatments adds to their appeal, particularly among patients seeking minimally invasive alternatives.

Considering these factors, the zygomatic implant segment is expected to witness robust growth in the zygomatic and pterygoid implant market during the forecast period of 2025 to 2032. The combination of clinical benefits, improved patient outcomes, and a rising edentulous population underscores the segment's potential for sustained market expansion.

North America is expected to dominate the overall zygomatic and pterygoid implant market:

North America is projected to hold the largest share of the zygomatic and pterygoid implant market in 2024 among all regions. This dominance is primarily driven by the increasing prevalence of oral disorders, rising trauma cases, aging population, and the presence of advanced healthcare infrastructure. Additionally, a highly favorable regulatory environment supporting product launches and approvals further strengthens the region's market position.

According to data from the National Institute of Dental and Craniofacial Research (NIDCR, 2022), approximately 90% of adults aged 20 to 64 years in the United States experienced tooth decay in 2022. Furthermore, periodontal (gum) disease affects over 40% of adults aged 45 to 64 annually. Such widespread oral health issues contribute significantly to tooth loss and upper jawbone deterioration, creating a robust demand for advanced dental solutions like zygomatic and pterygoid implants.

Cancer-related maxillofacial surgeries also play a crucial role in market growth. As per the American Cancer Society (2024), an estimated 58,450 new cases of oral cavity and oropharyngeal cancers will be diagnosed in the United States in 2024. Treatment often involves surgical resection of affected tissues, including portions of the maxilla (upper jaw), leading to significant bone loss that hinders the placement of traditional implants. Zygomatic and pterygoid implants offer an effective solution in such cases by anchoring into denser bones like the zygomatic bone (cheekbone), thus eliminating the need for bone grafting.

The aging population in North America further accelerates demand. Older adults are more susceptible to edentulism (tooth loss) and atrophic maxilla, both of which necessitate innovative rehabilitation solutions. With zygomatic implants enabling single-stage surgical placement and immediate loading protocols, patients benefit from faster recovery times and improved quality of life attributes that are particularly appealing in regions with high healthcare awareness.

Moreover, the well-established healthcare infrastructure in the United States and Canada facilitates easy access to advanced dental procedures. Frequent product innovations, strategic collaborations between key market players, and the presence of skilled dental professionals further propel the adoption of zygomatic and pterygoid implants.

Considering these factors, North America's dominance in the zygomatic and pterygoid implant market is expected to continue throughout the 2025 to 2032 forecast period, fueled by a combination of epidemiological trends, technological advancements, and patient-centric care initiatives.

Zygomatic and Pterygoid Implant Market Key Players:

Some of the key market players operating in the zygomatic and pterygoid implant market include Danaher Corporation, Noris Medical, Biotec Dental Impant, SIN Implant System, IDC Implant & Dental Company, BioLine Dental Implants, Southern Implants, B&B Dental Implant Company, BioHorizons, Titaniumfix, Implance, Institut Straumann AG, DSI Dental Solutions, JDentalCare, Adin Dental Implant Systems Ltd., and others.

Recent Developmental Activities in the Zygomatic and Pterygoid Implant Market:

  • In November 2023: The International Journal of Oral Implantology published the first-ever consensus on zygomatic implants, marking a pivotal milestone for both the ZAGA Centers Network and the broader clinical community involved in zygomatic implant rehabilitation. This consensus reflects the culmination of months of collaborative research and expert input, setting a new standard for clinical practice.
  • In October 2022: A clinical trial was launched in France to evaluate a robot-assisted, flapless approach for zygomatic implant placement. Sponsored by the Centre Hospitalier Universitaire (CHU) in Amiens, the study aims to explore the potential benefits of robotic technology in enhancing precision, reducing invasiveness, and improving patient recovery outcomes in complex implant procedures.

Key Takeaways from the Zygomatic and Pterygoid Implant Market Report Study

  • Market size analysis for current zygomatic and pterygoid Implant market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the zygomatic and pterygoid implant market.
  • Various opportunities available for the other competitors in the zygomatic and pterygoid implant market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current zygomatic and pterygoid implant market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Zygomatic and Pterygoid implant market growth in the coming future?

Target Audience Who Can be Benefited from this Zygomatic and Pterygoid Implant Market Report Study

  • Zygomatic and pterygoid Implant product providers
  • Research organizations and consulting companies
  • Zygomatic and Pterygoid Implant-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in zygomatic and pterygoid implant
  • Various end-users who want to know more about the zygomatic and pterygoid implant market and the latest technological developments in the zygomatic and pterygoid implant market.

Frequently Asked Questions for the Zygomatic and Pterygoid Implant Market:

1. What is meant by zygomatic and pterygoid implants?

  • Zygomatic and Pterygoid implants are specialized types of dental implants used to provide support for dental prosthetics (like crowns or dentures) in patients with insufficient bone structure in the upper jaw (maxilla), often due to bone loss or trauma. These implants offer an alternative to traditional implants that might fail due to a lack of adequate bone mass in the jaw.

2. What is the market for zygomatic and pterygoid implants?

  • The Zygomatic and Pterygoid Implant market is estimated to grow at a CAGR of 5.78% during the forecast period from 2025 to 2032.

3. What are the drivers for the global zygomatic and pterygoid implant market?

  • The demand for the zygomatic and pterygoid implants market is primarily being boosted by the increasing prevalence of oral disorders and trauma around the globe. Additionally, the growing demand for aesthetic dental solutions and cost-effectiveness compared to bone grafting are some of the factors that are contributing to the growth of the zygomatic and pterygoid implant market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the global zygomatic and pterygoid implant market?

  • Some of the key market players operating in the zygomatic and pterygoid implant market include Danaher Corporation, Noris Medical, Biotec Dental Impant, SIN Implant System, IDC Implant & Dental Company, BioLine Dental Implants, Southern Implants, B&B Dental Implant Company, BioHorizons, Titaniumfix, Implance, Institut Straumann AG, DSI Dental Solutions, JDentalCare, Adin Dental Implant Systems Ltd., and others.

5. Which region has the highest share in the global zygomatic and pterygoid Implant market?

  • North America is expected to dominate the overall zygomatic and pterygoid implant market during the forecast period, 2025 to 2032. This is due to the increasing prevalence of oral disorders in the region. Additionally, the growing incidence of trauma, the presence of sophisticated healthcare infrastructure, and a highly viable market in terms of product launches and approvals are some of the key factors driving the growth of the zygomatic and pterygoid implant market in North America.

Table of Contents

1. Zygomatic and Pterygoid Implant Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Zygomatic and Pterygoid Implant Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Zygomatic and Pterygoid Implant Market Key Factors Analysis

  • 5.1. Zygomatic and Pterygoid Implant Market Drivers
    • 5.1.1. Increasing prevalence of oral disorders and trauma around the globe
    • 5.1.2. Growing demand for aesthetic dental solutions
    • 5.1.3. Cost-Effectiveness compared to bone grafting
  • 5.2. Zygomatic and Pterygoid Implant Market Restraints and Challenges
    • 5.2.1. Post-surgical complications associated with the procedure
    • 5.2.2. Patient suitability and presence of alternative treatment options
  • 5.3. Zygomatic and Pterygoid Implant Market Opportunities
    • 5.3.1. Expanding the use of zygomatic and pterygoid implants in post-trauma and oncological applications

6. Zygomatic and Pterygoid Implant Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Zygomatic and Pterygoid Implant Market Assessment

  • 7.1. By Implant Type
    • 7.1.1. Zygomatic Implants
    • 7.1.2. Pterygoid Implants
  • 7.2. By Application
    • 7.2.1. Maxillary Sinuses
    • 7.2.2. Severe Maxillary Atrophy
    • 7.2.3. Others
  • 7.3. By End-Users
    • 7.3.1. Hospitals
    • 7.3.2. Dental Clinics
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.1.2. Canada Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.1.3. Mexico Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
    • 7.4.2. Europe
      • 7.4.2.1. France Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.2.2. Germany Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.2.3. United Kingdom Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.2.4. Italy Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.2.5. Spain Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.2.6. Rest of Europe Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.3.2. Japan Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.3.3. India Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.3.4. Australia Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.3.5. South Korea Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.3.6. Rest of Asia-Pacific Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.4.2. Africa Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)
      • 7.4.4.3. South America Zygomatic and Pterygoid Implant Market Size in USD million (2022-2032)

8. Zygomatic and Pterygoid Implant Market Company and Product Profiles

  • 8.1. Danaher Corporation
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Noris Medical
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Biotec Dental Impant
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. SIN Implant System
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. IDC Implant & Dental Company
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. BioLine Dental Implants
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Southern Implants
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. B&B Dental Implant Company
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. BioHorizons
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Titaniumfix
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Implance
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Institut Straumann AG
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. DSI Dental Solutions
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. JDentalCare
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Adin Dental Implant Systems Ltd.
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us